Therefore, our findings demonstrate that high expression of hnRNPK enhances the resistance of NPC cells to chemotherapy drugs at the cellular level, while artificial attenuating hnRNPK expression improves the sensitivity of NPC cells to chemotherapy drugs. Here, HNRNPK is linked to nasopharyngeal carcinoma.